Integrated WGCNA and Machine Learning Uncover ECM/Cell Cycle Hub Genes as Prognostic Biomarkers in Lung Adenocarcinoma for Improved Health Care
Journal of Clinical Medicine of Kazakhstan · 31.08.2026 · 23 (5) · 27-40
DOI: 10.23950/jcmk/19212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine of Kazakhstan, erschienen am 31.08.2026. Verfasst von Moksha Pradha Prabhakar und 3 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Introduction
Lung adenocarcinoma (LUAD) is the most common lung cancer subtype, carrying high mortality in global health. Dependable molecular risk assessment tools are urgently needed to complement current clinicopathological staging and improve prognostic accuracy.
Methods
Using dataset GSE75307, we performed differential expression and weighted gene co-expression network analysis (WGCNA). Functional insights were gained via GO/KEGG over-representation and pre-ranked gene set enrichment analyses. A protein–protein interaction (PPI) network was built using STRING, and Cytoscape/cytoHubba identified hub genes. Consensus machine learning-based feature selection was applied to isolate key prognostic genes, which were then validated using the TCGA-LUAD cohort (n = 515).
Results
We identified 442 unique differentially expressed genes, combining them with tumor-related WGCNA modules to yield 945 candidates enriched in extracellular matrix organization and cell cycle pathways. PPI analysis revealed 17 hub genes, ultimately narrowed down to a robust three-gene signature: TOP2A, CCNB1, and CDK1. In the TCGA-LUAD validation cohort, the model's risk score successfully stratified participant survival risk. The clinicopathological nomogram incorporating the three-gene risk score achieved a concordance index (C-index) of 0.784, although the standalone three-gene signature showed only modest discrimination in the time-dependent ROC analysis. High-risk tumors exhibited an immunosuppressive microenvironment, characterized by elevated M2 macrophage infiltration, upregulation of immune checkpoints (PDCD1, CTLA4), and TGF- β pathway activation.
Conclusion
This study established and validated a dependable three-gene transcriptomic signature (TOP2A, CCNB1, CDK1) that successfully stratifies LUAD survival risk and aligns with immunosuppressive tumor microenvironments, offering a valuable molecular tool to enhance lung cancer prognosis.
Zitieren
APA
Prabhakar, M. P., Ramasamy, N., Rahman, R. R., & Muthu, K. (2026). Integrated WGCNA and Machine Learning Uncover ECM/Cell Cycle Hub Genes as Prognostic Biomarkers in Lung Adenocarcinoma for Improved Health Care. Journal of Clinical Medicine of Kazakhstan, 23(5), 27-40. https://doi.org/10.23950/jcmk/19212
Vancouver
Prabhakar MP, Ramasamy N, Rahman RR, Muthu K. Integrated WGCNA and Machine Learning Uncover ECM/Cell Cycle Hub Genes as Prognostic Biomarkers in Lung Adenocarcinoma for Improved Health Care. Journal of Clinical Medicine of Kazakhstan. 2026;23(5):27-40. doi:10.23950/jcmk/19212
BibTeX
@article{Prabhakar2026,
author = {Prabhakar, Moksha Pradha and Ramasamy, Narmadha and Rahman, Rizwana Rohoofur and Muthu, Kannan},
title = {Integrated WGCNA and Machine Learning Uncover ECM/Cell Cycle Hub Genes as Prognostic Biomarkers in Lung Adenocarcinoma for Improved Health Care},
journal = {Journal of Clinical Medicine of Kazakhstan},
year = {2026},
volume = {23},
number = {5},
pages = {27--40},
doi = {10.23950/jcmk/19212}
}
EUVIMED